Close this search box.

Supreme Court mifepristone ruling slams lid on Pandora’s box

ARTICLE | Politics, Policy & Law

Court unanimously rejects notion that any physician can sue FDA over any regulatory action

By Steve Usdin, Washington Editor

June 13, 2024 11:07 PM UTC

The Supreme Court’s unanimous decision, released Thursday, to dismiss an attempt to overturn FDA’s decisions on access to the abortion drug mifepristone marks the end of a legal odyssey that threatened to undermine the agency’s ability to regulate medicines.

The ruling shuts a Pandora’s box that Judge Matthew Kacsmaryk of the U.S. District Court for the Northern District of Texas opened in April 2023 when he ruled that physicians with remote and largely imaginary connections to the approval and regulation of mifepristone had standing to sue the agency…